RAS-mediated oncogenic signaling pathways in human malignancies-Reference-Cited by-同舟云学术

RAS-mediated oncogenic signaling pathways in human malignancies

Published:2019-02 Issue: Volume:54 Page:1-13
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Khan Abdul Q.,Kuttikrishnan Shilpa,Siveen Kodappully S.^ORCID,Prabhu Kirti S.,Shanmugakonar Muralitharan,Al- Naemi Hamda A.,Haris Mohammad,Dermime Said,Uddin Shahab

Funder

Medical Research Center

Hamad Medical Corporation, Doha, State of Qatar

Publisher

Elsevier BV

Subject

Cancer Research

Reference234 articles.

1. The Ras protein superfamily: evolutionary tree and role of conserved amino acids;Rojas;J. Cell Biol.,2012

2. The Ras superfamily at a glance;Wennerberg;J. Cell Sci.,2005

3. The guanine nucleotide-binding switch in three dimensions;Vetter;Science,2001

4. Targeting oncogenic Ras signaling in hematologic malignancies;Ward;Blood,2012

5. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy;Vigil;Nat. Rev. Cancer,2010

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico Exploration of a Novel ICMT Inhibitor with More Solubility than Cysmethynil against Membrane Localization of KRAS Mutant in Colorectal Cancer;Current Computer-Aided Drug Design;2024-12

2. Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors;Oncogene;2024-08-16

3. A comprehensive view on the fisetin impact on colorectal cancer in animal models: Focusing on cellular and molecular mechanisms;Animal Models and Experimental Medicine;2024-08-13

4. Cycloheptylprodigiosin from marine bacterium Spartinivicinus ruber MCCC 1K03745T induces a novel form of cell death characterized by Golgi disruption and enhanced secretion of cathepsin D in non-small cell lung cancer cell lines;European Journal of Pharmacology;2024-07

5. Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma;HemaSphere;2024-07